An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor

Urological Research

Volumn 33, Issue 6, 2005, Pages 453-459

  Byong, Chang Jeong ^a   Min, Young Park ^a   Kwak, Cheol ^a   Bong, Sub Kim ^a   Kim, Jung In ^a,b   Hyeon, Hoe Kim ^a  

^a Seoul National University Hospital   (South Korea)

^b Inje University   (South Korea)

Author keywords

Animal model; Celecoxib; COX 2; Oxalate; Urolithiasis

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; GAMMA GLUTAMYLTRANSFERASE; OXALATE SODIUM; OXALIC ACID; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM OXALATE STONE; CONTROLLED STUDY; CREATININE CLEARANCE; CRYSTAL; ENZYME ACTIVITY; FEEDING BEHAVIOR; KIDNEY PAPILLA; KIDNEY TUBULE DISORDER; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; URINALYSIS; URINARY EXCRETION;

ANIMALS; CALCIUM OXALATE; CYCLOOXYGENASE 2 INHIBITORS; DISEASE MODELS, ANIMAL; KIDNEY TUBULES; LACTOBACILLUS; MALE; OXALOBACTER FORMIGENES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONAMIDES; URINARY CALCULI;

EID: 28844503765     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-005-0507-1     Document Type: Article

References (30)

1. Kahn SR, Hackett RL (1985) Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature. Scanning Elect Microsc 1985: 759
2. Kumar S, Sigmon D, Carpenter B, Khan S, Scheid C, Menon M et al. (1991) A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146: 1384
3. Kwak C, Kim HK, Kim EC, Choi MS, Kim HH (2003) Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 44: 475
4. Kleinschmidt K, Mahlmann A, Hautmann R (1993) Anaerobic oxalate-degrading bacteria in the gut decrease faecal and urinary oxalate concentrations in stone formers. In: Ryall R, Basis R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2. Plenum, New York, p 439
5. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, De Simone C et al. (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60: 1097
6. Kajander EO, Ciftcioglu N (1998) Nanobacteria: an alternative mechanism for pathogenic intra- and extracellular calcification and stone formation. Proc Natl Acad Sci U S A 95: 8274
7. Szasz G (1969) A kinetic photometric method for serum gamma-glutamyl transpeptidase. Clin Chem Acta 15: 124
8. Stirling JL (1969) Beta galactosidase, beta-glucosidase and N-acetyl-beta-glucosaminidase in human kidney. Clin Chim Acta 24: 189
9. Chiriboga J (1966) Purification and properties of oxalic acid oxidase. Arch Biochem Biophys 116: 516
10. Toftegoarrd NT (1976) A method for enzymatic determination of citrate in serum and urine. Scand J Clin Lab Invest 36: 513
11. Cohen SA, Sideman L (1979) Modification of the o-cresolphthalein complexone method for determining calcium. Clin Chem 25: 1519
12. Jaffe M (1886) Uber den Niederschlag, welchen Picrinsaure in normalen Harn erzeugt und über eine neue Reaction des Keratinins. Hoppe Zeylersz Physiol Chem 10: 391
13. Lyon ES, Borden TA, Vermeulen CW (1966) Experimental oxalate lithiasis produced with ethylene glycol. Invest Urol 4: 143
14. McIntosh GH, Belling GB, Bulman FH (1979) Experimental oxalate urolith formation in rats. Aust J Exp Biol Med Sci 57: 251
15. Randall A (1940) The etiology of primary renal calculus. Int Abs Surg 71: 209
16. Gill WB, Ruggiero K, Straus FH (1979) Crystallization studies in an urothelial-lined living test tube (the catheterized female rat bladder). I. Calcium oxalate crystal adhesion to the chemically injured rat bladder. Invest Urol 17: 257
17. Khan SR, Cockrell CA, Finlayson B et al. (1984) Crystal retention by injured urothelium of the rat urinary bladder. J Urol 132: 153
18. Khan SR, Finlayson B, Hackett RL (1982) Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla. Am J Pathol 107: 59
19. Tessitore N, Ortalda V, Fabris A et al. (1985) Renal acidification defects in patients with recurrent calcium nephrolithiasis. Nephron 41: 325
20. Sutton RA, Walker VR (1980) Responses to hydrochlorothiazide and acetazolamide in patients with calcium stones. Evidence suggesting a defect in renal tubular function. N Engl J Med 302: 709
21. 2 from rabbit kidney medulla. Biochem J 105: 1251
22. 2 as the principal vasodepressor lipid of rabbit renal medulla. Nature 215: 1298
23. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232
24. Dunn MD, Hood VL (1977) Prostaglandins and the kidney: an editorial review. Am J Physiol 233: 169
25. Herschman HR (1996) Prostaglandin synthase 2. Biochim Biophys Acta 1299: 125
26. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van de Putte LB, Lipsky PE (1998) Cyclooxygenase in biology and disease. FASEB J 12: 1063
27. Laudanno OM, Cesolari JA, Esnarriaga J, Rista L, Piombo G, Rocaspana A (2001) Gastrointestinal damage induced by celecoxib and rofecoxib in rats. Dig Dis Sci 46: 779
28. Chahwala SB, Harpur ES (1983) Gentamicin-induced hypercalciuria in the rat. Acta Pharmacol Toxicol 53: 358
29. Farell G, Huang E, Kim SY, Horstkorte R, Lieske JC (2004) Modulation of proliferating renal epithelial cell affinity for calcium oxalate monohydrate crystals. J Am Soc Nephrol 15: 3052
30. Bosomworth MP, Aparicio SR, Hay AW (1999) Urine N-acetyl-{beta}-D- glucosaminidase - a marker of tubular damage? Nephrol Dial Transplant 14: 620